International journal of gynecological cancer : official journal of the International Gynecological Cancer Society

Int J Gynecol Cancer · ISSN (e) 1525-1438 · 137 papers in corpus
other 2026
doi:10.1016/j.ijgc.2026.104613 ·PMID:41911632

OBJECTIVE: To determine whether large language models (LLMs) can automatically extract organ-level disease involvement to populate the Surgical Findings section of the European Society of Gynaecological Oncology (ESGO) Operative Report for …

other 2026
doi:10.1016/j.ijgc.2026.104742 ·PMID:42173755

Deep infiltrating endometriosis and oncologic radical pelvic surgeries pose a significant risk of nerve damage. A thorough understanding of pelvic anatomy is essential for surgical precision and to avoid neurological complications or dysfun…

review 2026
doi:10.1016/j.ijgc.2026.104676 ·PMID:42056783

Tubo-ovarian cancer represents the most lethal gynecologic malignancy, and its burden is compounded by the absence of effective screening and the substantial lifetime risk carried by women with germline BRCA1 or BRCA2 pathogenic variants. W…

observational 2026
doi:10.1016/j.ijgc.2025.102769 ·PMID:41274017

Opportunistic salpingectomy reduces ovarian cancer risk. To examine heterogeneity among physicians in their adoption of opportunistic salpingectomy in hysterectomy practice, we identified 33,401 non-pregnant patients aged 18 to 49 years in …

review 2025
doi:10.1016/j.ijgc.2025.101638 ·PMID:39914268

Mesonephric and mesonephric-like adenocarcinomas of the gynecologic tract are a rare subset of gynecologic tumors that are frequently associated with the presence of somatic KRAS mutations. Owing to their rare nature and ability to arise in…

other 2025
doi:10.1016/j.ijgc.2025.102876 ·PMID:41500903
other 2025
doi:10.1016/j.ijgc.2024.100014 ·PMID:39878272
observational 2025
doi:10.1016/j.ijgc.2025.101990 ·PMID:40685312

OBJECTIVE: Mesonephric-like adenocarcinoma is a rare, aggressive ovarian cancer subtype, newly classified by the World Health Organization in 2020. This study examines the clinical, ultrasound, pathological features, and survival outcomes o…

other 2025
doi:10.1016/j.ijgc.2025.101979 ·PMID:40639279

The presence of Fusobacterium nucleatum has been associated with gynecological disorders, namely endometriosis and pregnancy complications; however, its role in endometrial cancer remains unexplored. This study aimed to assess the presence …

other 2025
doi:10.1016/j.ijgc.2025.101804 ·PMID:40252599
observational 2025
doi:10.1016/j.ijgc.2024.100025 ·PMID:39878280

OBJECTIVE: Several reproductive factors are associated with ovarian cancer risk but the association with survival is less clear. The main aim was to examine the impact of pre-diagnostic reproductive factors on long-term ovarian cancer survi…

observational 2025
doi:10.1016/j.ijgc.2025.101634 ·PMID:39955191

OBJECTIVE: This study aimed to describe 2 types of endometriosis-associated ovarian cancer: those with transitional elements (atypical endometriosis and borderline tumors) termed endometriosis-correlated or incidental benign endometriosis v…

other 2024
doi:10.1136/ijgc-2024-005617 ·PMID:38658018
observational 2024
doi:10.1136/ijgc-2023-005139 ·PMID:38531540

OBJECTIVE: To compare survival outcomes and patterns of recurrence between endometriosis-associated ovarian cancer patients and non-endometriosis-associated ovarian cancer patients. METHODS: This retrospective study included data of consec…

review 2024
doi:10.1136/ijgc-2023-005127 ·PMID:38438183

The management of gynecological cancer has evolved considerably over the past decades in almost every field of treatment. Surgery plays a major role in the treatment algorithm. However, these invasive interventions can have profound implica…

observational 2024
doi:10.1136/ijgc-2024-005332 ·PMID:38862154

OBJECTIVES: Primary mucinous ovarian carcinoma represents 3% of ovarian cancers and is typically diagnosed early, yielding favorable outcomes. This study aims to identify risk factors, focussing on the impact of age and ethnicity on surviva…

observational 2024
doi:10.1136/ijgc-2023-005194 ·PMID:38508587

OBJECTIVES: To investigate the association of molecular and pathologic factors with concurrent or recurrent ovarian disease to guide ovarian preservation in endometrioid endometrial cancer. METHODS: Patients with endometrial cancer ≤50 yea…

other 2024
doi:10.1016/j.ijgc.2024.100055 ·PMID:39971440
other 2024
doi:10.1136/ijgc-2024-005553 ·PMID:39622545
review 2024
doi:10.1136/ijgc-2023-004583 ·PMID:38438171
other 2023
doi:10.1136/igc.0000000000001137corr1 ·PMID:37011926
guideline 2023
doi:10.1136/ijgc-2023-004429 ·PMID:37127326

In 2018, the European Society of Gynecological Oncology (ESGO) jointly with the European Society for Radiotherapy and Oncology (ESTRO) and the European Society of Pathology (ESP) published evidence-based guidelines for the management of pat…

case-report 2023
doi:10.1136/ijgc-2022-004151 ·PMID:37543373

A 51-year-old pre-menopausal patient underwent a laparoscopic ovarian cystectomy for persistent bilateral cysts. Pathology analysis revealed borderline endometrioid tumors on both ovaries[1][1] ([Figures 1–4][2]). A secondary review confirm…

other 2023
doi:10.1136/ijgc-2022-004072 ·PMID:37127325
meta-analysis 2023
doi:10.1136/ijgc-2022-004014 ·PMID:36914172

OBJECTIVE: In endometrial carcinoma patients, sentinel lymph node bilateral mapping fails in 20-25% of cases, with several factors affecting the likelihood of detection. However, pooled data about predictive factors of failure are lacking. …